Mumps

A year of enhanced surveillance in Catalonia, Spain

Angela Dominguez, Manuel Oviedo, Nuria Torner, Gloria Carmona, Josep Costa, Joan Caylà, M. Rosa Sala, Irene Barrabeig, Neus Camps, Sofia Minguell, Josep Alvarez, Pere Godoy, Josep M. Jansà

Research output: Contribution to journalArticle

Abstract

Mumps is a vaccine-preventable disease candidate for elimination. Positive predictive value (PPV) of clinical case definition was assessed. During 2007, 410 suspected cases were reported in Catalonia: 348 fulfilled clinical case definition and 159 were laboratory confirmed. Incidence rate was 4.8 per 100,000 for cases that fulfilled the clinical definition, and 2.2 for laboratory confirmed cases. Global PPV was 44.5%; 38.5% in

Original languageEnglish (US)
Pages (from-to)3492-3495
Number of pages4
JournalVaccine
Volume27
Issue number25-26
DOIs
StatePublished - May 26 2009
Externally publishedYes

Fingerprint

Mumps
Spain
Disease Eradication
monitoring
Vaccines
vaccines
incidence
Incidence

Keywords

  • Enhanced surveillance
  • Laboratory confirmation
  • Mumps

ASJC Scopus subject areas

  • Immunology and Microbiology(all)
  • Infectious Diseases
  • Public Health, Environmental and Occupational Health
  • veterinary(all)
  • Molecular Medicine

Cite this

Dominguez, A., Oviedo, M., Torner, N., Carmona, G., Costa, J., Caylà, J., ... Jansà, J. M. (2009). Mumps: A year of enhanced surveillance in Catalonia, Spain. Vaccine, 27(25-26), 3492-3495. https://doi.org/10.1016/j.vaccine.2009.03.022

Mumps : A year of enhanced surveillance in Catalonia, Spain. / Dominguez, Angela; Oviedo, Manuel; Torner, Nuria; Carmona, Gloria; Costa, Josep; Caylà, Joan; Sala, M. Rosa; Barrabeig, Irene; Camps, Neus; Minguell, Sofia; Alvarez, Josep; Godoy, Pere; Jansà, Josep M.

In: Vaccine, Vol. 27, No. 25-26, 26.05.2009, p. 3492-3495.

Research output: Contribution to journalArticle

Dominguez, A, Oviedo, M, Torner, N, Carmona, G, Costa, J, Caylà, J, Sala, MR, Barrabeig, I, Camps, N, Minguell, S, Alvarez, J, Godoy, P & Jansà, JM 2009, 'Mumps: A year of enhanced surveillance in Catalonia, Spain', Vaccine, vol. 27, no. 25-26, pp. 3492-3495. https://doi.org/10.1016/j.vaccine.2009.03.022
Dominguez A, Oviedo M, Torner N, Carmona G, Costa J, Caylà J et al. Mumps: A year of enhanced surveillance in Catalonia, Spain. Vaccine. 2009 May 26;27(25-26):3492-3495. https://doi.org/10.1016/j.vaccine.2009.03.022
Dominguez, Angela ; Oviedo, Manuel ; Torner, Nuria ; Carmona, Gloria ; Costa, Josep ; Caylà, Joan ; Sala, M. Rosa ; Barrabeig, Irene ; Camps, Neus ; Minguell, Sofia ; Alvarez, Josep ; Godoy, Pere ; Jansà, Josep M. / Mumps : A year of enhanced surveillance in Catalonia, Spain. In: Vaccine. 2009 ; Vol. 27, No. 25-26. pp. 3492-3495.
@article{99930d3e442641e7add054f565b9e678,
title = "Mumps: A year of enhanced surveillance in Catalonia, Spain",
abstract = "Mumps is a vaccine-preventable disease candidate for elimination. Positive predictive value (PPV) of clinical case definition was assessed. During 2007, 410 suspected cases were reported in Catalonia: 348 fulfilled clinical case definition and 159 were laboratory confirmed. Incidence rate was 4.8 per 100,000 for cases that fulfilled the clinical definition, and 2.2 for laboratory confirmed cases. Global PPV was 44.5{\%}; 38.5{\%} in",
keywords = "Enhanced surveillance, Laboratory confirmation, Mumps",
author = "Angela Dominguez and Manuel Oviedo and Nuria Torner and Gloria Carmona and Josep Costa and Joan Cayl{\`a} and Sala, {M. Rosa} and Irene Barrabeig and Neus Camps and Sofia Minguell and Josep Alvarez and Pere Godoy and Jans{\`a}, {Josep M.}",
year = "2009",
month = "5",
day = "26",
doi = "10.1016/j.vaccine.2009.03.022",
language = "English (US)",
volume = "27",
pages = "3492--3495",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",
number = "25-26",

}

TY - JOUR

T1 - Mumps

T2 - A year of enhanced surveillance in Catalonia, Spain

AU - Dominguez, Angela

AU - Oviedo, Manuel

AU - Torner, Nuria

AU - Carmona, Gloria

AU - Costa, Josep

AU - Caylà, Joan

AU - Sala, M. Rosa

AU - Barrabeig, Irene

AU - Camps, Neus

AU - Minguell, Sofia

AU - Alvarez, Josep

AU - Godoy, Pere

AU - Jansà, Josep M.

PY - 2009/5/26

Y1 - 2009/5/26

N2 - Mumps is a vaccine-preventable disease candidate for elimination. Positive predictive value (PPV) of clinical case definition was assessed. During 2007, 410 suspected cases were reported in Catalonia: 348 fulfilled clinical case definition and 159 were laboratory confirmed. Incidence rate was 4.8 per 100,000 for cases that fulfilled the clinical definition, and 2.2 for laboratory confirmed cases. Global PPV was 44.5%; 38.5% in

AB - Mumps is a vaccine-preventable disease candidate for elimination. Positive predictive value (PPV) of clinical case definition was assessed. During 2007, 410 suspected cases were reported in Catalonia: 348 fulfilled clinical case definition and 159 were laboratory confirmed. Incidence rate was 4.8 per 100,000 for cases that fulfilled the clinical definition, and 2.2 for laboratory confirmed cases. Global PPV was 44.5%; 38.5% in

KW - Enhanced surveillance

KW - Laboratory confirmation

KW - Mumps

UR - http://www.scopus.com/inward/record.url?scp=67349257170&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67349257170&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2009.03.022

DO - 10.1016/j.vaccine.2009.03.022

M3 - Article

VL - 27

SP - 3492

EP - 3495

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 25-26

ER -